Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Cash & Equivalents (2016 - 2026)

Eastman Chemical (EMN) has disclosed Cash & Equivalents for 18 consecutive years, with $665.0 million as the latest value for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 59.09% year-over-year to $665.0 million; the TTM value through Mar 2026 reached $665.0 million, up 59.09%, while the annual FY2025 figure was $566.0 million, 32.38% down from the prior year.
  • Cash & Equivalents hit $665.0 million in Q1 2026 for Eastman Chemical, up from $566.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $837.0 million in Q4 2024 and bottomed at $410.0 million in Q2 2023.
  • Average Cash & Equivalents over 5 years is $525.1 million, with a median of $493.0 million recorded in 2022.
  • Year-over-year, Cash & Equivalents crashed 35.7% in 2022 and then soared 59.09% in 2026.
  • Eastman Chemical's Cash & Equivalents stood at $493.0 million in 2022, then grew by 11.16% to $548.0 million in 2023, then surged by 52.74% to $837.0 million in 2024, then plummeted by 32.38% to $566.0 million in 2025, then grew by 17.49% to $665.0 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $665.0 million, $566.0 million, and $489.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.